MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

MDT

88.49

+0.49%↑

A

115.97

-0.64%↓

VEEV

157.32

-7.12%↓

HQY

83.84

+2.66%↑

TLRY

6.83

+1.49%↑

Strona główna・Stock List・Nektar Therapeutics

Search

Nektar Therapeutics

Open

77.6 3.62

Overview

Share price change

24h

Current

Min

73.55

Max

77.76

Key metrics
By Trading Economics
Income	-557K -36M
Sales	10M 22M
EPS	-1.29
Profit margin	-165.447
Employees	63
EBITDA	10M -19M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+52.6% upside

Dividends
By Dow Jones
Next Earnings	7 maj 2026

Market Stats
By TradingEconomics
Market Cap	209M 2.1B
Previous open	73.98
Previous close	77.6

Technical Score

By Trading Central

Confidence

Strong Bearish Evidence

0.5949 / 0.7406 Support & Resistance

Nektar Therapeutics Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

8 kwi 2026, 20:44 UTC

Earnings

Costco Reports 11% Growth in March Sales

8 kwi 2026, 23:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 kwi 2026, 23:51 UTC

Market Talk

Nikkei May Rise on Hopes for Talks to End Iran War -- Market Talk

8 kwi 2026, 23:36 UTC

Market Talk

Major News Events

Gold Edges Lower on Likely Technical Correction -- Market Talk

8 kwi 2026, 22:56 UTC

Market Talk

Ramelius Resources May Downgrade Cost Guidance This Month -- Market Talk

8 kwi 2026, 22:45 UTC

Market Talk

Constellation Brands Points to Continuing Challenges Among Hispanic Consumers -- Market Talk

8 kwi 2026, 22:17 UTC

Market Talk

Applied Digital Says Its Holding Out for Quality Customers -- Market Talk

8 kwi 2026, 21:52 UTC

Major News Events

A Closer Look at Iran's 10 Demands -- and Which the U.S. Might Accept -- Update

8 kwi 2026, 21:24 UTC

Earnings

FedEx Freight Aims for 12% Profit Growth. How That Compares to the Leader. -- Barrons.com

8 kwi 2026, 21:01 UTC

Major News Events

Oil Prices Tumble Despite Conflicting Reports About the Strait of Hormuz -- Barrons.com

8 kwi 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle Is Expressing No Opinion and Is Neutral as to Whether Stockholders Should Tender Their Shrs in Response to TRC's Offer >ORCL

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle Does Not Endorse TRC's Mini-Tender Offer or the Offer Documentation >ORCL

8 kwi 2026, 20:43 UTC

Acquisitions, Mergers, Takeovers

Oracle: Offer Represents Less Than 0.04% of Outstanding Common Stk >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle: TRC Offer Is to Purchase Up to 1M Shrs of Common Stk at $140.50/Shr in Cash >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle Received Notice of Unsolicited Mini-Tender Offer by TRC Dated March 24 >ORCL

8 kwi 2026, 20:42 UTC

Acquisitions, Mergers, Takeovers

Oracle Responds to TRC Cap Mini-Tender Offer

8 kwi 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: Repurchased 49% Equity Interest in JV Related to Intel's Fab 34 in Ireland >INTC

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: $14.2B Repurchase Price Financed with Cash on Hand and a Bridge Loan of $6.5B >INTC

8 kwi 2026, 20:11 UTC

Acquisitions, Mergers, Takeovers

Intel Corp.: Repurchased JV Stake From Apollo-Managed Funds and Affiliates >INTC

8 kwi 2026, 19:44 UTC

Earnings

These Companies Pay 5% Dividend Yields, and They're Hiking Them Too -- Barrons.com

8 kwi 2026, 19:16 UTC

Market Talk

Hogs Follow Cutout Prices Lower -- Market Talk

8 kwi 2026, 19:02 UTC

Market Talk

Global Energy Roundup: Market Talk

8 kwi 2026, 19:02 UTC

Market Talk

Oil Futures Plunge as Cease-Fire Raises Hopes for Restored Supply -- Market Talk

8 kwi 2026, 18:58 UTC

Market Talk

U.S. Natural Gas Futures Fall in Line With Slump in Oil -- Market Talk

8 kwi 2026, 18:51 UTC

Market Talk

Global Equities Roundup: Market Talk

8 kwi 2026, 18:51 UTC

Market Talk

Levi Strauss CEO Says Expanded Offerings, DTC Focus Are Working -- Market Talk

8 kwi 2026, 18:14 UTC

Major News Events

Fed Minutes Suggest a Lengthy Iran War Could Lead to Rate Hikes -- Barrons.com

8 kwi 2026, 18:05 UTC

Major News Events

Oil Prices Continue to Tumble After Cease-Fire Despite Slow Reopening of Strait of Hormuz -- Barrons.com

Peer Comparison

Price change

Nektar Therapeutics Forecast

Price Target

By TipRanks

52.6% upside

12 Months Forecast

Average 114.57 USD 52.6%

High 151 USD

Low 68 USD

Based on 8 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

8 ratings

7

Buy

1

Hold

0

Sell

Based on 8 analysts giving stock ratings to Nektar Therapeutics - Dist in the past 3 months.

Technical Score

By Trading Central

0.5949 / 0.7406Support & Resistance

Recent bearish events outweigh bullish events.

All events are bearish.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

MDT

Medtronic PLC

88.49

A

Agilent Technologies Inc

115.97

VEEV

Veeva Systems Inc

157.32

HQY

HealthEquity Inc

83.84

TLRY

Tilray Brands Inc

6.83

Live chat